Historical record - last NADAC effective date: 2/18/2015
Product Information
DIAZEPAM 5 MG/ML SYRINGE is a generic product labeled by Hospira Inc., priced at $5.2875 per ML under NDC 00409127332. Its NADAC has been published 121 times since Nov 28, 2013.
FDA first approved this application on Dec 20, 1988. Its Orange Book therapeutic-equivalence code is AP.
Strength
5 mg/mL
Manufacturer
Hospira Inc.NDC
00409127332
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
2/18/2015
Active Ingredients
DIAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA072079FDA Approved
12/20/1988
TE Code
AP
On Market Since
8/23/2005
Pharmacological Classes
Price Statistics
The NADAC for DIAZEPAM 5 MG/ML SYRINGE has been published 121 times since Nov 28, 2013, and over the history we have for it it has risen 25.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.2875 per ML |
|---|---|
| All-time high | $5.3757 (Jan 14, 2015) |
| All-time low | $4.2279 (Nov 28, 2013) |
| Median price | $5.2875 |
| Average price | $5.1653 |
| Largest weekly change | +21.1% (Mar 19, 2014) |
| Weeks tracked | 121 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+25.1%
Last surveyed Mar 16, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DIAZEPAM market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DIAZEPAM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIAZEPAM 5 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for DIAZEPAM 5 MG/ML SYRINGE, manufactured by Hospira Inc., is $5.2875 per ML (NDC 00409127332), effective Mar 16, 2016.
How has the price of DIAZEPAM 5 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for DIAZEPAM 5 MG/ML SYRINGE has risen 25.1%. It has been tracked across 121 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DIAZEPAM 5 MG/ML SYRINGE?
Since Nov 28, 2013, the NADAC for DIAZEPAM 5 MG/ML SYRINGE has ranged from a low of $4.2279 (Nov 28, 2013) to a high of $5.3757 (Jan 14, 2015), with a median of $5.2875 per ML.
Are there cheaper alternatives to DIAZEPAM 5 MG/ML SYRINGE?
No other NADAC-published product currently shares the active ingredient and strength of DIAZEPAM 5 MG/ML SYRINGE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DIAZEPAM 5 MG/ML SYRINGE?
DIAZEPAM 5 MG/ML SYRINGE (NDC 00409127332) is labeled by Hospira Inc., and CMS classifies it as a generic product.